Sign up by using the form below and stay up to date with the latest developments in the European pharmaceutical and life sciences industry.
If you want to change your preferences just fill in this form again using the same email address or click the update preferences or unsubscribe links in any of the emails we send.
Latest content
- Roche’s Tecentriq gets FDA Priority Review for specific stage 3 colon cancer
- Oriva Therapeutics appoints Agnès Arbat as CEO
- Lilly’s Ebglyss approved by FDA as maintenance dose for atopic dermatitis
- The next frontier in clinical trials: navigating multi-disease research with GLP-1s
- GSK to acquire biopharma Nuvalent for $10.6bn
Latest intelligence
- The next frontier in clinical trials: navigating multi-disease research with GLP-1s
- Headline trade and market deals are opening doors to greater patient access
- Men’s health: the gap between awareness and action is where men’s lives are lost
- The digital age and the advance of AI – pushing communications to new heights
- GenAI: embracing the transformation – with caution




